Greg Stein, MD, MBA

Gregory Stein, MD, MBA, is a co-founder and CEO of Curtana Pharmaceuticals, a clinical-stage biopharmaceutical company focused on innovative treatments for brain cancers. With extensive experience in the pharmaceutical and biotechnology sectors, Gregory has held key roles such as Senior Vice President of Clinical Development at PLUS THERAPEUTICS and Co-Founder and Vice President of Operations at Sova Pharmaceuticals, Inc. Notable past positions include serving on the Board of Directors at Revolutions, Inc., President of Nautilus Life Science Group, and Emergency Physician at MacNeal Hospital. Gregory holds an MBA in Entrepreneurship and Biotech Strategy from the University of California, San Diego, and an MD from The Ohio State University College of Medicine, among other academic qualifications.